Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis

To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset (early-onset LN).PURPOSETo compare the clinical character...

Full description

Saved in:
Bibliographic Details
Published inYonsei medical journal Vol. 61; no. 11; pp. 951 - 957
Main Authors Kwon, Oh Chan, Park, Jung Hwan, Lee, Sang-Won, Song, Jason Jungsik, Park, Yong-Beom, Park, Min-Chan
Format Journal Article
LanguageEnglish
Published Yonsei University College of Medicine 01.11.2020
연세대학교의과대학
Subjects
Online AccessGet full text
ISSN0513-5796
1976-2437
1976-2437
DOI10.3349/ymj.2020.61.11.951

Cover

Loading…
Abstract To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset (early-onset LN).PURPOSETo compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset (early-onset LN).SLE patients with biopsy-proven LN were retrospectively reviewed. The clinical parameters and renal outcomes were compared between initial-onset and early-onset LN groups. We used Cox regression analysis to estimate risk of worse renal outcomes according to the onset time of LN.MATERIALS AND METHODSSLE patients with biopsy-proven LN were retrospectively reviewed. The clinical parameters and renal outcomes were compared between initial-onset and early-onset LN groups. We used Cox regression analysis to estimate risk of worse renal outcomes according to the onset time of LN.Of all 136 LN patients, 92 (67.6%) and 44 (32.4%) patients were classified into the initial-onset and early-onset LN groups, respectively. The initial-onset LN group had higher prevalences of class IV LN (54.3% vs. 34.1%, p=0.027), impaired renal function (34.8% vs. 11.4%, p=0.004), microscopic hematuria (73.9% vs. 54.5%, p=0.024), and higher urine protein/creatinine ratio [4626.1 (2180.0-6788.3) mg/g vs. 2410.0 (1265.0-5168.5) mg/g, p=0.006] at LN diagnosis. Renal relapse (46.3% vs. 25.7%, p=0.039) and progression to chronic kidney disease (CKD) or end-stage renal disease (ESRD) were more common (24.4% vs. 8.3%, p=0.042) in the initial-onset LN group. In Cox regression analysis, the initial-onset LN group had higher risks of renal relapse [adjusted hazard ratio (HR) 3.56, 95% confidence interval (CI) 1.51-8.35, p=0.004] and progression to CKD or ESRD (adjusted HR 4.57, 95% CI 1.03-20.17, p=0.045), compared with the early-onset LN group.RESULTSOf all 136 LN patients, 92 (67.6%) and 44 (32.4%) patients were classified into the initial-onset and early-onset LN groups, respectively. The initial-onset LN group had higher prevalences of class IV LN (54.3% vs. 34.1%, p=0.027), impaired renal function (34.8% vs. 11.4%, p=0.004), microscopic hematuria (73.9% vs. 54.5%, p=0.024), and higher urine protein/creatinine ratio [4626.1 (2180.0-6788.3) mg/g vs. 2410.0 (1265.0-5168.5) mg/g, p=0.006] at LN diagnosis. Renal relapse (46.3% vs. 25.7%, p=0.039) and progression to chronic kidney disease (CKD) or end-stage renal disease (ESRD) were more common (24.4% vs. 8.3%, p=0.042) in the initial-onset LN group. In Cox regression analysis, the initial-onset LN group had higher risks of renal relapse [adjusted hazard ratio (HR) 3.56, 95% confidence interval (CI) 1.51-8.35, p=0.004] and progression to CKD or ESRD (adjusted HR 4.57, 95% CI 1.03-20.17, p=0.045), compared with the early-onset LN group.Patients with LN at SLE onset may have more severe renal presentations and experience worse renal outcomes than those who develop LN within 5 years.CONCLUSIONPatients with LN at SLE onset may have more severe renal presentations and experience worse renal outcomes than those who develop LN within 5 years.
AbstractList To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset (early-onset LN).PURPOSETo compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset (early-onset LN).SLE patients with biopsy-proven LN were retrospectively reviewed. The clinical parameters and renal outcomes were compared between initial-onset and early-onset LN groups. We used Cox regression analysis to estimate risk of worse renal outcomes according to the onset time of LN.MATERIALS AND METHODSSLE patients with biopsy-proven LN were retrospectively reviewed. The clinical parameters and renal outcomes were compared between initial-onset and early-onset LN groups. We used Cox regression analysis to estimate risk of worse renal outcomes according to the onset time of LN.Of all 136 LN patients, 92 (67.6%) and 44 (32.4%) patients were classified into the initial-onset and early-onset LN groups, respectively. The initial-onset LN group had higher prevalences of class IV LN (54.3% vs. 34.1%, p=0.027), impaired renal function (34.8% vs. 11.4%, p=0.004), microscopic hematuria (73.9% vs. 54.5%, p=0.024), and higher urine protein/creatinine ratio [4626.1 (2180.0-6788.3) mg/g vs. 2410.0 (1265.0-5168.5) mg/g, p=0.006] at LN diagnosis. Renal relapse (46.3% vs. 25.7%, p=0.039) and progression to chronic kidney disease (CKD) or end-stage renal disease (ESRD) were more common (24.4% vs. 8.3%, p=0.042) in the initial-onset LN group. In Cox regression analysis, the initial-onset LN group had higher risks of renal relapse [adjusted hazard ratio (HR) 3.56, 95% confidence interval (CI) 1.51-8.35, p=0.004] and progression to CKD or ESRD (adjusted HR 4.57, 95% CI 1.03-20.17, p=0.045), compared with the early-onset LN group.RESULTSOf all 136 LN patients, 92 (67.6%) and 44 (32.4%) patients were classified into the initial-onset and early-onset LN groups, respectively. The initial-onset LN group had higher prevalences of class IV LN (54.3% vs. 34.1%, p=0.027), impaired renal function (34.8% vs. 11.4%, p=0.004), microscopic hematuria (73.9% vs. 54.5%, p=0.024), and higher urine protein/creatinine ratio [4626.1 (2180.0-6788.3) mg/g vs. 2410.0 (1265.0-5168.5) mg/g, p=0.006] at LN diagnosis. Renal relapse (46.3% vs. 25.7%, p=0.039) and progression to chronic kidney disease (CKD) or end-stage renal disease (ESRD) were more common (24.4% vs. 8.3%, p=0.042) in the initial-onset LN group. In Cox regression analysis, the initial-onset LN group had higher risks of renal relapse [adjusted hazard ratio (HR) 3.56, 95% confidence interval (CI) 1.51-8.35, p=0.004] and progression to CKD or ESRD (adjusted HR 4.57, 95% CI 1.03-20.17, p=0.045), compared with the early-onset LN group.Patients with LN at SLE onset may have more severe renal presentations and experience worse renal outcomes than those who develop LN within 5 years.CONCLUSIONPatients with LN at SLE onset may have more severe renal presentations and experience worse renal outcomes than those who develop LN within 5 years.
Purpose: To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) atthe onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset(early-onset LN). Materials and Methods: SLE patients with biopsy-proven LN were retrospectively reviewed. The clinical parameters and renaloutcomes were compared between initial-onset and early-onset LN groups. We used Cox regression analysis to estimate risk ofworse renal outcomes according to the onset time of LN. Results: Of all 136 LN patients, 92 (67.6%) and 44 (32.4%) patients were classified into the initial-onset and early-onset LN groups,respectively. The initial-onset LN group had higher prevalences of class IV LN (54.3% vs. 34.1%, p=0.027), impaired renal function(34.8% vs. 11.4%, p=0.004), microscopic hematuria (73.9% vs. 54.5%, p=0.024), and higher urine protein/creatinine ratio [4626.1(2180.0–6788.3) mg/g vs. 2410.0 (1265.0–5168.5) mg/g, p=0.006] at LN diagnosis. Renal relapse (46.3% vs. 25.7%, p=0.039) andprogression to chronic kidney disease (CKD) or end-stage renal disease (ESRD) were more common (24.4% vs. 8.3%, p=0.042) inthe initial-onset LN group. In Cox regression analysis, the initial-onset LN group had higher risks of renal relapse [adjusted hazardratio (HR) 3.56, 95% confidence interval (CI) 1.51–8.35, p=0.004] and progression to CKD or ESRD (adjusted HR 4.57, 95% CI1.03–20.17, p=0.045), compared with the early-onset LN group. Conclusion: Patients with LN at SLE onset may have more severe renal presentations and experience worse renal outcomes thanthose who develop LN within 5 years. KCI Citation Count: 0
Author Lee, Sang-Won
Park, Jung Hwan
Kwon, Oh Chan
Song, Jason Jungsik
Park, Yong-Beom
Park, Min-Chan
AuthorAffiliation Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
AuthorAffiliation_xml – name: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
Author_xml – sequence: 1
  givenname: Oh Chan
  orcidid: 0000-0001-7962-3697
  surname: Kwon
  fullname: Kwon, Oh Chan
  organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
– sequence: 2
  givenname: Jung Hwan
  orcidid: 0000-0003-2911-2711
  surname: Park
  fullname: Park, Jung Hwan
  organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
– sequence: 3
  givenname: Sang-Won
  orcidid: 0000-0002-8038-3341
  surname: Lee
  fullname: Lee, Sang-Won
  organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
– sequence: 4
  givenname: Jason Jungsik
  orcidid: 0000-0003-0662-7704
  surname: Song
  fullname: Song, Jason Jungsik
  organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
– sequence: 5
  givenname: Yong-Beom
  orcidid: 0000-0003-4695-8620
  surname: Park
  fullname: Park, Yong-Beom
  organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
– sequence: 6
  givenname: Min-Chan
  orcidid: 0000-0003-1189-7637
  surname: Park
  fullname: Park, Min-Chan
  organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002638083$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kU9r3DAQxUVJSTZpvkBPPrYHuxr9saxLIYS0XViaEBJ6FLI9zirxSlvJDuy3rzYbCi2lp4HR7z3NzDslRz54JOQ90IpzoT_tNo8Vo4xWNVQAlZbwhixAq7pkgqsjsqASeCmVrk_IaUqPlDIFlB2TE86BKsabBVn_CDFhcYvejsVNxIR-spMLvrC-z43w4ENyqXC-WHo3OTuW1z7hVKzm7ZyK77hdx9xOxbS2vriycdz9G3hH3g52THj-Ws_I_Zeru8tv5er66_LyYlV2AvhUIjBp-56yTjPLW636pml6C2pQig0IYHGQLYheQCs4Co20HhRvaFOjGFrgZ-TjwdfHwTx1zgTrXupDME_RXNzeLY2WmoHQmf18YLdzu8G-y7tHO5ptdBsbdy_KP1-8W2efZ6Okzhek2eDDq0EMP2dMk9m41OE4Wo9hToYJKWopZV1nlB3QLoaUIg6_vwFq9nGaHKfZx2lqMAB5yP0yzV-izh3iyeO48X_SX_5jqHE
CitedBy_id crossref_primary_10_1093_rheumatology_keae236
crossref_primary_10_1177_09612033211030008
crossref_primary_10_1177_09612033231220726
crossref_primary_10_1016_j_ejr_2024_12_005
crossref_primary_10_1016_j_ekir_2024_10_021
crossref_primary_10_14412_1996_7012_2022_6_12_19
crossref_primary_10_7759_cureus_66270
crossref_primary_10_31450_ukrjnd_2_78__2023_08
Cites_doi 10.1002/art.1780400928
10.1002/art.10461
10.1016/S0140-6736(14)60128-8
10.1038/nrneph.2017.85
10.1093/rheumatology/ker101
10.1038/ki.2010.13
10.1053/j.ajkd.2014.01.416
10.2215/CJN.00490109
10.1007/s10157-015-1179-y
10.1097/01.ASN.0000108969.21691.5D
10.1056/NEJM200010193431604
10.1056/NEJM198603063141004
10.1136/annrheumdis-2012-201940
10.1097/MD.0000000000002891
10.1136/ard.62.6.556
10.1136/annrheumdis-2014-206897
10.3109/s10165-009-0154-4
10.1191/0961203305lu2057oa
10.1007/s12016-010-8249-4
10.1177/0961203319860200
10.1136/ard.2008.088740
ContentType Journal Article
Copyright Copyright: Yonsei University College of Medicine 2020.
Copyright: Yonsei University College of Medicine 2020 2020 Yonsei University College of Medicine
Copyright_xml – notice: Copyright: Yonsei University College of Medicine 2020.
– notice: Copyright: Yonsei University College of Medicine 2020 2020 Yonsei University College of Medicine
DBID AAYXX
CITATION
7X8
5PM
ACYCR
DOI 10.3349/ymj.2020.61.11.951
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1976-2437
EndPage 957
ExternalDocumentID oai_kci_go_kr_ARTI_9592149
PMC7593100
10_3349_ymj_2020_61_11_951
GrantInformation_xml – fundername: ;
  grantid: 6-2019-0111
GroupedDBID ---
.55
.GJ
123
29R
2WC
36B
5-W
53G
5RE
8JR
8XY
9ZL
AAYXX
ACYCR
ADBBV
ADRAZ
AEGXH
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
CS3
DIK
DU5
E3Z
EBD
EF.
EMB
EMOBN
F5P
GROUPED_DOAJ
GX1
HYE
KQ8
L7B
M48
MK0
O5R
O5S
OK1
OVT
P2P
PGMZT
RNS
RPM
SV3
TR2
X7M
XSB
ZGI
ZXP
7X8
5PM
ID FETCH-LOGICAL-c413t-e125add02c92a3b97d888da17f772fe11aef5b14d41b43e49e06f738086e4fb13
IEDL.DBID M48
ISSN 0513-5796
1976-2437
IngestDate Sun Mar 09 07:50:41 EDT 2025
Thu Aug 21 18:45:30 EDT 2025
Fri Jul 11 00:35:33 EDT 2025
Tue Jul 01 04:03:20 EDT 2025
Thu Apr 24 22:56:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c413t-e125add02c92a3b97d888da17f772fe11aef5b14d41b43e49e06f738086e4fb13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
https://www.eymj.org/DOIx.php?id=10.3349/ymj.2020.61.11.951
ORCID 0000-0003-0662-7704
0000-0002-8038-3341
0000-0003-1189-7637
0000-0001-7962-3697
0000-0003-4695-8620
0000-0003-2911-2711
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3349/ymj.2020.61.11.951
PMID 33107238
PQID 2454655566
PQPubID 23479
PageCount 7
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9592149
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7593100
proquest_miscellaneous_2454655566
crossref_primary_10_3349_ymj_2020_61_11_951
crossref_citationtrail_10_3349_ymj_2020_61_11_951
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-11-01
PublicationDateYYYYMMDD 2020-11-01
PublicationDate_xml – month: 11
  year: 2020
  text: 2020-11-01
  day: 01
PublicationDecade 2020
PublicationTitle Yonsei medical journal
PublicationYear 2020
Publisher Yonsei University College of Medicine
연세대학교의과대학
Publisher_xml – name: Yonsei University College of Medicine
– name: 연세대학교의과대학
References Mok (10.3349/ymj.2020.61.11.951_ref8) 2005; 14
Gladman (10.3349/ymj.2020.61.11.951_ref12) 2002; 29
Takahashi (10.3349/ymj.2020.61.11.951_ref10) 2009; 19
Inker (10.3349/ymj.2020.61.11.951_ref20) 2014; 63
Houssiau (10.3349/ymj.2020.61.11.951_ref16) 2002; 46
Bertsias (10.3349/ymj.2020.61.11.951_ref18) 2012; 71
Yu (10.3349/ymj.2020.61.11.951_ref3) 2017; 13
Weening (10.3349/ymj.2020.61.11.951_ref13) 2004; 15
Tamirou (10.3349/ymj.2020.61.11.951_ref22) 2016; 75
Austin (10.3349/ymj.2020.61.11.951_ref17) 1986; 314
Galindo-Izquierdo (10.3349/ymj.2020.61.11.951_ref5) 2016; 95
Hochberg (10.3349/ymj.2020.61.11.951_ref11) 1997; 40
Yu (10.3349/ymj.2020.61.11.951_ref14) 2010; 77
Lisnevskaia (10.3349/ymj.2020.61.11.951_ref1) 2014; 384
Nakano (10.3349/ymj.2020.61.11.951_ref21) 2019; 28
Alba (10.3349/ymj.2020.61.11.951_ref2) 2003; 62
Chan (10.3349/ymj.2020.61.11.951_ref15) 2000; 343
Gibson (10.3349/ymj.2020.61.11.951_ref19) 2009; 4
Varela (10.3349/ymj.2020.61.11.951_ref9) 2008; 67
Croca (10.3349/ymj.2020.61.11.951_ref4) 2011; 50
Anaya (10.3349/ymj.2020.61.11.951_ref7) 2011; 40
Imran (10.3349/ymj.2020.61.11.951_ref6) 2016; 20
References_xml – volume: 40
  start-page: 1725
  year: 1997
  ident: 10.3349/ymj.2020.61.11.951_ref11
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780400928
– volume: 46
  start-page: 2121
  year: 2002
  ident: 10.3349/ymj.2020.61.11.951_ref16
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10461
– volume: 384
  start-page: 1878
  year: 2014
  ident: 10.3349/ymj.2020.61.11.951_ref1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)60128-8
– volume: 13
  start-page: 483
  year: 2017
  ident: 10.3349/ymj.2020.61.11.951_ref3
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2017.85
– volume: 50
  start-page: 1424
  year: 2011
  ident: 10.3349/ymj.2020.61.11.951_ref4
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/ker101
– volume: 77
  start-page: 820
  year: 2010
  ident: 10.3349/ymj.2020.61.11.951_ref14
  publication-title: Kidney Int
  doi: 10.1038/ki.2010.13
– volume: 29
  start-page: 288
  year: 2002
  ident: 10.3349/ymj.2020.61.11.951_ref12
  publication-title: J Rheumatol
– volume: 63
  start-page: 713
  year: 2014
  ident: 10.3349/ymj.2020.61.11.951_ref20
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2014.01.416
– volume: 4
  start-page: 1962
  year: 2009
  ident: 10.3349/ymj.2020.61.11.951_ref19
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.00490109
– volume: 20
  start-page: 1
  year: 2016
  ident: 10.3349/ymj.2020.61.11.951_ref6
  publication-title: Clin Exp Nephrol
  doi: 10.1007/s10157-015-1179-y
– volume: 15
  start-page: 241
  year: 2004
  ident: 10.3349/ymj.2020.61.11.951_ref13
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000108969.21691.5D
– volume: 343
  start-page: 1156
  year: 2000
  ident: 10.3349/ymj.2020.61.11.951_ref15
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200010193431604
– volume: 314
  start-page: 614
  year: 1986
  ident: 10.3349/ymj.2020.61.11.951_ref17
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198603063141004
– volume: 71
  start-page: 1771
  year: 2012
  ident: 10.3349/ymj.2020.61.11.951_ref18
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-201940
– volume: 95
  start-page: e2891
  year: 2016
  ident: 10.3349/ymj.2020.61.11.951_ref5
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000002891
– volume: 62
  start-page: 556
  year: 2003
  ident: 10.3349/ymj.2020.61.11.951_ref2
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.62.6.556
– volume: 75
  start-page: 526
  year: 2016
  ident: 10.3349/ymj.2020.61.11.951_ref22
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2014-206897
– volume: 19
  start-page: 293
  year: 2009
  ident: 10.3349/ymj.2020.61.11.951_ref10
  publication-title: Mod Rheumatol
  doi: 10.3109/s10165-009-0154-4
– volume: 14
  start-page: 39
  year: 2005
  ident: 10.3349/ymj.2020.61.11.951_ref8
  publication-title: Lupus
  doi: 10.1191/0961203305lu2057oa
– volume: 40
  start-page: 199
  year: 2011
  ident: 10.3349/ymj.2020.61.11.951_ref7
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-010-8249-4
– volume: 28
  start-page: 1062
  year: 2019
  ident: 10.3349/ymj.2020.61.11.951_ref21
  publication-title: Lupus
  doi: 10.1177/0961203319860200
– volume: 67
  start-page: 1044
  year: 2008
  ident: 10.3349/ymj.2020.61.11.951_ref9
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2008.088740
SSID ssj0027102
Score 2.2853038
Snippet To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus...
Purpose: To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) atthe onset of systemic lupus...
SourceID nrf
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 951
SubjectTerms Original
의학일반
Title Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis
URI https://www.proquest.com/docview/2454655566
https://pubmed.ncbi.nlm.nih.gov/PMC7593100
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002638083
Volume 61
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Yonsei Medical Journal, 2020, 61(11), , pp.951-957
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELa2ISFeED9FGVQG8YZc6sRO4geEEGLaEB0IUW1vVpyct7LibEkrsf-euyTdiDQQT5GSixPd2b777PN3jL3SEcSJ00qoCLRQGkC4VJYtbWWsvELsQ-sds8Nkf64-HevjLbYpd9QrsLkR2lE9qXm9nPy6uHyHA_4tIc5YmTeXP38g0Iumk0TiDDAxdKL6FnqmhHr5TGXXAEx2OYjoggUR8XWHaP7SxsBRbYfaD2LQYQblHy5p7x6728eS_H1n_PtsC8IDdnvW75Y_ZKdHVd0A_wYk9fX6nFHgeSjxRkVJdouGLwI_oByifCm-hAZW_PP6fN3wQ0BDE-URp-V13lIh3yzwiM33Pn7_sC_6ygqiQKe1EoBhDU5s06gwUR47k5YIhMtcph6DbQ9S5uC1k6pU0qkYlIFp4tM4Q_wDyjsZP2Y7oQrwhHGfGZ-6OFMm06osUoczKEKakighp2VWjJjcqNEWPe04Vb9YWoQfpHqLqrekeptIxCMWVT9ir6_eOe9IN_4p_RKtY8-KhSWubLqeVPastogIDlDARIgCR-zFxngWBxDtiuQBqnVjI0X14DWGtSOWDqx69W1qdvgkLE5bKu5UG9ohefofre-yO_Tf3TnGZ2xnVa_hOQY0Kzdm21ocjdvlgHHbY38DttL09g
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Worse+Renal+Presentation+and+Prognosis+in+Initial-Onset+Lupus+Nephritis+than+Early-Onset+Lupus+Nephritis&rft.jtitle=Yonsei+medical+journal&rft.au=Kwon%2C+Oh+Chan&rft.au=Park%2C+Jung+Hwan&rft.au=Lee%2C+Sang+Won&rft.au=Song%2C+Jason+Jungsik&rft.date=2020-11-01&rft.issn=1976-2437&rft.eissn=1976-2437&rft.volume=61&rft.issue=11&rft.spage=951&rft_id=info:doi/10.3349%2Fymj.2020.61.11.951&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0513-5796&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0513-5796&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0513-5796&client=summon